-

$undefined

N/A

(N/A)

Sagimet Biosciences :SGMT

Location: | Industry: | Sector:


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-80.02M

Cash

151.3M

Avg Qtr Burn

-10.61M

Short % of Float

19.30%

Insider Ownership

14.65%

Institutional Own.

58.00%

Qtr Updated

12/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 3

Data readout

Phase 3

Data readout

Denifanstat Details
Metabolic-dysfunction Associated Steatohepatitis

Phase 3

Initiation

Denifanstat Details
Non-alcoholic steatohepatitis

Phase 2

Update

Phase 1

Update

Phase 1

Initiation